HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website Save this grant

Next deadline: Jul 16, 2024

Later deadlines: Oct 16, 2024, Nov 16, 2024, Feb 16, 2025, Mar 16, 2025, Jun 16, 2025, Jul 16, 2025, Oct 16, 2025, Nov 16, 2025, Feb 16, 2026, Mar 16, 2026, Jun 16, 2026, Jul 16, 2026

Grant amount: Up to US $100,000

Fields of work: Drug Use Disorder Chronic / Acute Pain Anesthesia and Pain Medicine

Applicant type: Nonprofit, Government Entity, Indigenous Group, For-Profit Business

Funding uses: Research

Location of project: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico Show all

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico Show all

Overview:

NOTE: The following deadlines apply to standard grant applications (due by 5:00 pm local time of applicant organization):

  • June 16, 2024
  • October 16, 2024
  • February 16, 2025
  • June 16 , 2025
  • October 16, 2025
  • February 16, 2026
  • June 16, 2026
The following deadlines apply to Renewal/Resubmission/Revision grant applications (due by 5:00 pm local time of applicant organization): 

  • July 16, 2024
  • November 16, 2024
  • March 16, 2025
  • July 16 , 2025
  • November 16, 2025
  • March 16, 2026
  • July 16, 2026
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for pilot projects to identify new druggable targets for pain within the understudied druggable proteome. Awards will support generation of preliminary data and/or tools around eligible understudied protein(s) listed in this NOFO. This NOFO is intended to jumpstart research on understudied proteins within the context of pain and pain management and provide applicants with sufficient funding to perform basic biochemical and/or biological work to further the characterization of understudied proteins to identify new druggable targets for pain. This NOFO is part of the NIH Helping to End Addiction Long Term (HEAL) initiative to accelerate the development of novel medications to treat all aspects of the opioid addiction cycle, including progression to chronic use, withdrawal symptoms, craving, relapse, and overdose.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

US Dept. of Health & Human Services: National Institutes of Health (NIH)
FUNDER

Your history with this funder
0
SAVED OPPORTUNITIES
No saved opportunities from this funder yet
FUNDER NOTES
Save this opportunity to add notes...
CONTACTS
Save this opportunity to add contacts...

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

Don't miss out on other good fit funders!

Get personalized grant recommendations, tracking and more by creating a free 14-day account.

No credit card required.
instrumentl testimonial face

"Winning 30% more grants thanks to Instrumentl was a huge morale boost. My confidence continues to grow."

Linda Rucker, Grant Writer

This page was last reviewed April 19, 2024 and last updated April 19, 2024